Customers

You are here

Fujirebio
In April 2019, Novosanis signed a worldwide, non-exclusive distribution agreement with Fujirebio, a global leader in the field of in vitro diagnostics (IVD), for use of Colli-Pee® with...
GAP
Novosanis has set-up a distribution agreement with GAP for supply of its Colli-Pee device in Mexico. GAP is a young and enterprising Mexican company, dedicated to the commercialization and...
Diagnolita
Novosanis supplies its Colli-Pee device to Diagnolita as part of their convenience kit for detection of prostate cancer. Diagnolita is based in Lithuania.
MDxHealth
Novosanis has signed an agreement with MDxHealth to supply UrNCollect ™ , a customized version of the company’s patented urine collection device called Colli-Pee ™. The medical device...

Pages